HomeNewsBusinessProduction at SAIL, Tata Steel plants down by 50%, amid lockdown: Sources

Production at SAIL, Tata Steel plants down by 50%, amid lockdown: Sources

State-owned Steel Authority of India Ltd (SAIL) and private player Tata Steel both contribute about 20 per cent to India's total steel production.

April 07, 2020 / 14:15 IST
Story continues below Advertisement

Facing reduction in demand due to the lockdown in the country, steel makers SAIL and Tata Steel have reduced their output by about 50 per cent, according to sources.

State-owned Steel Authority of India Ltd (SAIL) and private player Tata Steel both contribute about 20 per cent to India's total steel production.         As per industry sources, SAIL and Tata Steel have scaled down production by about 50 per cent.

Story continues below Advertisement

The companies have taken the decision because of the reduced demand in the market after the lockdown, which has impacted logistics movement, the sources said adding that buyers are also reluctant in placing orders.

Most of the staff of the companies are working from home and only important sites like blast furnaces and coke oven batteries etc at the plants, which can not be closed, are running.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show